Skip to main content
Organigram Holdings Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.480
+0.030 (2.07%)
Nov 20, 2024, 4:00 PM EST - Market closed

Organigram Holdings Revenue

In the fiscal year ending September 30, 2023, Organigram Holdings had annual revenue of 149.21M CAD with 2.33% growth. Organigram Holdings had revenue of 41.06M in the quarter ending June 30, 2024, with 3.97% growth.

Revenue (ttm)
149.21M CAD
Revenue Growth
+2.33%
P/S Ratio
n/a
Revenue / Employee
151,631 CAD
Employees
984
Market Cap
160.50M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023149.21M3.40M2.33%
Aug 31, 2022145.81M66.65M84.19%
Aug 31, 202179.16M-7.63M-8.79%
Aug 31, 202086.80M6.38M7.94%
Aug 31, 201980.41M67.98M546.98%
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro
Aug 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nevro 419.15M
Nutex Health 292.00M
Fulcrum Therapeutics 80.87M
2seventy bio 45.62M
KORU Medical Systems 31.99M
scPharmaceuticals 30.28M
Jin Medical International 20.13M
Revenue Rankings

OGI News

More News